证券集体诉讼
搜索文档
LFMD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Globenewswire· 2025-10-06 11:20
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding In LifeMD To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 05, 2025 (GLOBE NEWSWIRE) -- Faru ...
KBR Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against KBR, Inc. - KBR
Prnewswire· 2025-10-04 10:35
法律诉讼概况 - 针对KBR公司的证券集体诉讼正在美国德克萨斯州南区地方法院进行,投资者提交首席原告申请的截止日期为2025年11月18日 [1] - 诉讼指控KBR及其部分高管在2025年5月6日至2025年6月19日期间未能披露重大信息,违反了联邦证券法 [3] - 该案件案号为Norrman诉KBR公司等,编号25-cv-04464 [5] 事件触发点与市场影响 - 2025年6月19日,KBR持股72%的合资企业HomeSafe Alliance披露,其收到了美国国防部运输司令部的通知,终止了其在2021年赢得的全球家居用品合同 [4] - 在此消息公布后,KBR股价于2025年6月20日下跌3.85美元,跌幅达7.29%,收于48.93美元 [4] - 在下一个交易日(2025年6月23日),KBR股价进一步下跌1.30美元,跌幅2.65%,收于47.63美元 [4]
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages KBR, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KBR
Globenewswire· 2025-10-04 03:01
NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of KBR, Inc. (NYSE: KBR) between May 6, 2025 and June 19, 2025, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased KBR securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs thro ...
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
Prnewswire· 2025-10-03 21:50
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Altimmune To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Altimmune between August 10, 2023 and June 25, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330Â (Ext. 1310). [You may also click here for additional information] , /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading ...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Quantum
Prnewswire· 2025-10-02 23:55
Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Quantum Corporation To Contact Him Directly To Discuss Their Options If you suffered losses in Quantum Corporation between November 15, 2024 and August 18, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330Â (Ext. 1310). [You may also click here for additional information] NEW ...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PubMatic
Prnewswire· 2025-10-02 23:51
Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In PubMatic To Contact Him Directly To Discuss Their Options The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve ...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of V.F. Corporation
Prnewswire· 2025-10-02 22:20
Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In VFC To Contact Him Directly To Discuss Their Options If you suffered losses in VFC between October 30, 2023 and May 20, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330Â (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 2, 2025 /PRNewswire/ -- ...
Levi & Korsinsky Reminds KBR, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 18, 2025 - KBR
Prnewswire· 2025-10-01 20:45
集体诉讼案件核心 - 律师事务所Levi & Korsinsky对KBR公司提起证券集体诉讼 旨在为在2025年5月6日至2025年6月19日期间遭受损失的投资者追回损失 [1] 诉讼指控内容 - 指控KBR公司管理层做出虚假陈述和/或隐瞒事实 尽管已知美国国防部运输司令部对HomeSafe履行全球家居用品合同的能力存在重大担忧 但公司声称该合作伙伴关系没有问题 并将在未来几个季度加速发展 [2] - 因此 KBR公司关于其业务 运营和前景的陈述在所有相关时间点均存在重大虚假和误导性 和/或缺乏合理依据 [2] 诉讼程序信息 - 受损失的投资者可在2025年11月18日前向法院申请担任首席原告 参与赔偿无需担任首席原告 也无需支付任何自付费用或成本 [3]
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific
Markets.Businessinsider.Com· 2025-09-27 20:37
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Semler Scientific To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Semler Scientific between March 10, 2021 and April 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. ...
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
Globenewswire· 2025-09-26 06:11
NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2025. SO WHAT: If you purchased Jasper Therapeutics secu ...